Europe

Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Mon, 08/14/17 - 10:04 am
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
Kite shoots for first CAR-T OK in Europe, staying one step behind Novartis in US race
Endpoints
Mon, 07/31/17 - 09:57 am
Kite Pharma
CAR-T
Europe
Novartis
axicabtagene ciloleucel
EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
Sat, 07/22/17 - 12:23 pm
EMA
Europe
Pfizer
Bavencio
Novartis
Rydapt
Lexicon Pharmaceuticals
Xermelo
Vanda
Fanaptum
Nektar
Onzeald
Daiichi Sankyo
Nektar’s pitch on early cancer drug OK runs into a regulatory brick wall
Endpoints
Sat, 07/22/17 - 09:57 am
Nektar
regulatory
Onzeald
Europe
Daiichi Sankyo
What Brexit means for drug regulation
Pharmafile
Sun, 07/16/17 - 03:42 pm
regulation
UK
Europe
Brexit
EMA Restricts Use of Biogen MS Drug
RAPS.org
Sun, 07/9/17 - 11:39 am
Europe
EMA
Biogen
MS
multiple sclerosis
Zinbryta
EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts
Fierce Biotech
Thu, 07/6/17 - 05:58 pm
Europe
biotech
Brexit
BioNTech
GSK
artificial intelligence
Sanofi
Exscientia
Silence Therapeutics
RNAi
Lilly’s Olumiant, spurned by FDA, gets nod from NICE
Fierce Pharma
Sat, 07/1/17 - 09:26 am
FDA
NICE
Europe
Eli Lilly
olumiant
rheumatoid arthritis
Humira
Janssen gets EU nod for continuous manufacturing
BioPharma Dive
Fri, 06/30/17 - 09:45 am
Janssen
Europe
drug manufacturing
Prezista
HIV
Novartis scores second biosimilar approval in two weeks
BioPharma Dive
Thu, 06/29/17 - 09:43 am
Novartis
biosimilars
Enbrel
Europe
Sandoz
Erelzi
Roche
Rituxan
Aveo soars as long-beleaguered cancer drug nears approval
Fierce Biotech
Sat, 06/24/17 - 09:23 am
Aveo
Europe
tivozanib
kidney cancer
Takeda set to open new German manufacturing facilities
BioPharma Dive
Sat, 06/24/17 - 09:13 am
Takeda
Germany
Europe
drug manufacturing
EMA Recommends New HCV, Cancer and MS Drugs for Approval
RAPS.org
Sat, 06/24/17 - 09:11 am
Europe
EMA
hepatitis C
multiple sclerosis
breast cancer
renal cell carcinoma
AbbVie
Maviret
Gilead Sciences
Vosevi
Biogen
Amgen
Samsung Bioepis
biosimilars
Humira
Novartis
Kisqali
EUSA
Fotivda
Novo Nordisk files to add Lantus-matching CV data to Tresiba's European label
Fierce Pharma
Fri, 06/16/17 - 09:35 am
Novo Nordisk
Lantus
Tresiba
diabetes
Europe
EMA
insulin
Johnson & Johnson wins last regulatory nod needed for Actelion acquisition
Drug Delivery Business News
Sat, 06/10/17 - 12:14 pm
JNJ
Actelion
M&A
EU
Europe
Pfizer’s Trumenba to challenge GlaxoSmithKline's Bexsero with EU nod
Fierce Pharma
Wed, 05/31/17 - 09:23 am
Pfizer
Trumenba
GSK
Bexsero
Europe
vaccines
meningococcal B
EMA recommends 11 drugs for approval in May meeting
BioPharma Dive
Thu, 05/25/17 - 09:26 am
EMA
Europe
Sanofi
AstraZeneca
LEO Pharma
Novartis
Pfizer
Sanofi’s insulin biosimilar wins EMA committee recommendation
Drug Delivery Business News
Mon, 05/22/17 - 09:36 am
Sanofi
insulin
biosimilars
EMA
Europe
Lispro
EU drugmakers urge June decision on new location for watchdog
Yahoo/Reuters
Mon, 04/24/17 - 10:01 am
Europe
EMA
Brexit
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
Yahoo/Reuters
Sat, 04/22/17 - 01:14 pm
Europe
EMA
Sanofi
Regeneron
rheumatoid arthritis
Kevzara
Sarilumab

Pages